Page last updated: 2024-09-04

resiquimod and Psoriasis

resiquimod has been researched along with Psoriasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Catherine Jin, SL; Chang, CH; Chuang, TH; Hsu, LC; Lai, CY; Liu, YL; Lu, CH; Su, YW; Yeh, DW1
Di, T; Li, P; Lin, Y; Liu, X; Meng, Y; Ruan, Z; Wang, M; Wang, N; Wang, Y; Xie, X; Zhang, L; Zhao, J1

Other Studies

2 other study(ies) available for resiquimod and Psoriasis

ArticleYear
Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: Animals; Cell Cycle; Cell Differentiation; Computational Biology; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Inflammation; Macrophages; Mice; Mice, Inbred BALB C; Psoriasis; THP-1 Cells; Toll-Like Receptor 7; Toll-Like Receptors

2018
Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway.
    International immunopharmacology, 2016, Volume: 40

    Topics: Animals; Cell Differentiation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Imidazoles; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-23; Lithospermum; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Naphthoquinones; Psoriasis; Skin; Toll-Like Receptor 7; Toll-Like Receptor 8

2016